CXCL13 and lung adenocarcinoma: The apoptotic pathway and CXCL13 have been reported only in a few diseases such as breast cancer, lung adenocarcinoma, and cerebrovascular disease (Rayasam et al. 2022; Smedbakken et al. 2012; Tian et al. 2021).